The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain

被引:73
作者
Carlo, Anne-Sophie [1 ]
Gustafsen, Camilla [2 ]
Mastrobuoni, Guido [1 ]
Nielsen, Morten S. [2 ]
Burgert, Tilman [1 ]
Hartl, Daniela [3 ]
Rohe, Michael [1 ]
Nykjaer, Anders [2 ]
Herz, Joachim [4 ]
Heeren, Joerg [5 ]
Kempa, Stefan [1 ]
Petersen, Claus Munck [2 ]
Willnow, Thomas E. [1 ]
机构
[1] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany
[2] Univ Aarhus, Dept Biomed, MIND Ctr, DK-8000 Aarhus, Denmark
[3] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany
[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Clin Hamburg Eppendorf, D-20246 Hamburg, Germany
关键词
DENSITY-LIPOPROTEIN RECEPTOR; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; MOUSE MODEL; INTRACELLULAR DOMAIN; CEREBROSPINAL-FLUID; TRANSGENIC MICE; TYPE-4; ALLELE;
D O I
10.1523/JNEUROSCI.2425-12.2013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein E (APOE) is the major risk factor for sporadic Alzheimer's disease. Among other functions, APOE is proposed to sequester neurotoxic amyloid-beta (A beta) peptides in the brain, delivering them to cellular catabolism via neuronal APOE receptors. Still, the receptors involved in this process remain controversial. Here, we identified the pro-neurotrophin receptor sortilin as major endocytic pathway for clearance of APOE/A beta complexes in neurons. Sortilin binds APOE with high affinity. Lack of receptor expression in mice results in accumulation of APOE and of A beta in the brain and in aggravated plaque burden. Also, primary neurons lacking sortilin exhibit significantly impaired uptake of APOE/A beta complexes despite proper expression of other APOE receptors. Despite higher than normal brain APOE levels, sortilin-deficient animals display anomalies in brain lipid metabolism (e.g., accumulation of sulfatides) seen in APOE-deficient mice, indicating functional deficiency in cellular APOE uptake pathways. Together, our findings identified sortilin as an essential neuronal pathway for APOE-containing lipoproteins in vivo and suggest an intriguing link between A beta catabolism and pro-neurotrophin signaling converging on this receptor.
引用
收藏
页码:358 / 370
页数:13
相关论文
共 62 条
  • [11] Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
    Farris, W
    Mansourian, S
    Chang, Y
    Lindsley, L
    Eckman, EA
    Frosch, MP
    Eckman, CB
    Tanzi, RE
    Selkoe, DJ
    Guénette, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 4162 - 4167
  • [12] BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin
    Finan, Gina M.
    Okada, Hirokazu
    Kim, Tae-Wan
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (14) : 12602 - 12616
  • [13] The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice
    Fryer, JD
    DeMattos, RB
    McCormick, LM
    O'Dell, MA
    Spinner, ML
    Bales, KR
    Paul, SM
    Sullivan, PM
    Parsadanian, M
    Bu, GJ
    Holtzman, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) : 25754 - 25759
  • [14] ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN
    GAMES, D
    ADAMS, D
    ALESSANDRINI, R
    BARBOUR, R
    BERTHELETTE, P
    BLACKWELL, C
    CARR, T
    CLEMENS, J
    DONALDSON, T
    GILLESPIE, F
    GUIDO, T
    HAGOPIAN, S
    JOHNSONWOOD, K
    KHAN, K
    LEE, M
    LEIBOWITZ, P
    LIEBERBURG, I
    LITTLE, S
    MASLIAH, E
    MCCONLOGUE, L
    MONTOYAZAVALA, M
    MUCKE, L
    PAGANINI, L
    PENNIMAN, E
    POWER, M
    SCHENK, D
    SEUBERT, P
    SNYDER, B
    SORIANO, F
    TAN, H
    VITALE, J
    WADSWORTH, S
    WOLOZIN, B
    ZHAO, J
    [J]. NATURE, 1995, 373 (6514) : 523 - 527
  • [15] Novel role for apolipoprotein E in the central nervous system - Modulation of sulfatide content
    Han, XL
    Cheng, H
    Fryer, JD
    Fagan, AM
    Holtzman, DM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) : 8043 - 8051
  • [16] Astroglial regulation of apolipoprotein E expression in neuronal cells - Implications for Alzheimer's disease
    Harris, FM
    Tesseur, I
    Brecht, WJ
    Xu, Q
    Mullendorff, K
    Chang, SJ
    Wyss-Coray, T
    Mahley, RW
    Huang, YD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) : 3862 - 3868
  • [17] Heeren J, 1999, J CELL SCI, V112, P349
  • [18] Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
    Hesse, C
    Larsson, H
    Fredman, P
    Minthon, L
    Andreason, N
    Davidsson, P
    Blennow, K
    [J]. NEUROCHEMICAL RESEARCH, 2000, 25 (04) : 511 - 517
  • [19] Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
    Holtzman, David M.
    Herz, Joachim
    Bu, Guojun
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (03):
  • [20] Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
    Holtzman, DM
    Bales, KR
    Wu, S
    Bhat, P
    Parsadanian, M
    Fagan, AM
    Chang, LK
    Sun, YL
    Paul, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) : R15 - R21